XCT 790,
XCT-790,
XCT790,
XCT790,
725247-18-7,
XCT 790,
XCT-790,
CHEMBL189753,
CHEBI:79999,
MFCD08277031,
3-[4-(2,4-Bis-trifluoromethylbenzyloxy)-3-methoxyphenyl]-2-cyano-N-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)acrylamide,
(E)-3-[4-[[2,4-bis(trifluoromethyl)phenyl]methoxy]-3-methoxyphenyl]-2-cyano-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]prop-2-enamide,
AC1OCFVT,
GTPL2832,
C23H13F9N4O3S,
DTXSID40426088,
HMS3263N08,
BCP08393,
EX-A1708,
Tox21_501263,
BDBM50155833,
FD5021,
ZINC14191684,
AKOS024457878,
CCG-222567,
CS-2413,
LP01263,
NCGC00165952-01,
NCGC00165952-02,
NCGC00261948-01,
XCT790, >=98% (HPLC), solid,
4CA-1353,
BC600476,
BCB03_000874,
HY-10426,
AB0087827,
RT-016270,
Y1862,
C15641,
BRD-K00044672-001-01-8,
(E)-3-[4-[[2, 4-bis(trifluoromethyl)phenyl]methoxy]-3-methoxyphenyl]-2-cyano-N-[5- (trifluoromethyl)-1,3,4-thiadiazol-2-yl]prop-2-enamide,
3-(4-(2,4-bis(trifluoromethyl)benzyloxy)-3-methoxyphenyl)-2-cyano-N-(5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl)acrylamide,
3-(4-{[2,4-bis(trifluoromethyl)phenyl]methoxy}-3-methoxyphenyl)-2-cyano-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]prop-2-enamide,
3-[4-(2,4-Bis-trifluoromethyl-benzyloxy)-3-methoxy-phenyl]-2-cyano-N-(5-trifluoromethyl-[1,3,4]thiadiazol-2-yl)-acrylamide,
796844-24-1,
D0ZB7Z,
X4753_SIGMA,
CID6918788,
B3238,
A13299,
C488234,